Medical Device | December 07, 2021
Wipro-GE unveils B2B e-commerce platform for medical equipment
It is an extension of GE Healthcare’s online service delivery enterprise Service Shop
It is an extension of GE Healthcare’s online service delivery enterprise Service Shop
SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint
According to a survey conducted by FOGSI last year, 92% of the doctors opined that anaemia due to iron deficiency can be eradicated in five years
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Subscribe To Our Newsletter & Stay Updated
